Newly Bagang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Newly Bagang has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Nitesh Kumar
Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research (NIPER), Hajipur, India
3 shared publications - Smita Shenoy
Department of Pharmacology, Kasturba Medical College, Manipal Academy of Higher Education, Manipal, India
3 shared publications - Somasish Ghosh Dastidar
Department of Anatomy, Kasturba Medical College, Manipal Academy of Higher Education, Manipal, India
3 shared publications - Aqsa Fathima
Department of Pharmacology Kasturba Medical College Manipal Academy of Higher Education Manipal India manipal.edu
2 shared publications - Ajay Mili
Department of Pharmacognosy, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal, Karnataka-576104, India
1 shared publication Anoop Kishore
Manipal Academy of Higher Education
1 shared publication
Latest Publications
- Open Access
- 28 June 2026
- Published by Veterinary World in Veterinary World
- Vol. 19 (6) , 2650-2666
Melatonin attenuates fluoride-induced neurotoxicity and cognitive dysfunction through modulation of oxidative stress, neuroinflammation, and SIRT1 signaling in Wistar rats
Background and Aim: Chronic fluoride exposure causes neurotoxicity, oxidative stress, neuroinflammation, and cognitive impairment, posing a significant public health concern. This study investigated the neuroprotective potential of melatonin against fluoride-induced neurotoxicity and cognitive dysfunction in male and female Wistar rats, with emphasis on oxidative stress, neuroinflammation, apoptosis, and sirtuin 1 (SIRT1) signaling. Materials and Methods: Four-week-old Wistar albino rats (n=8 per group per sex) were exposed to sodium fluoride (NaF, 50 ppm in drinking water) alone or co-treated with melatonin (10 or 20 mg/kg, oral) for 8 weeks. Cognitive function was assessed using the Morris Water Maze (MWM) and Novel Object Recognition Test (NORT). Serum fluoride, brain SIRT1, oxidative stress markers (malondialdehyde [MDA], superoxide dismutase [SOD]), apoptosis markers (caspase-3, B-cell lymphoma 2 [Bcl-2]), inflammatory cytokines (tumor necrosis factor-α [TNF-α], interleukin-6 [IL-6]), acetylcholinesterase (AChE) levels, and hippocampal histopathology were evaluated. Results: NaF exposure significantly elevated serum fluoride, reduced brain SIRT1, increased oxidative stress, apoptosis, neuroinflammation, AChE activity, and caused hippocampal neuronal damage, leading to impaired learning and memory in both sexes (p < 0.05). Melatonin co-treatment (both doses) significantly attenuated these changes by lowering serum fluoride, restoring SIRT1 levels, reducing MDA, caspase-3, TNF-α, IL-6, and AChE, while increasing SOD and Bcl-2. It also improved behavioral performance in the MWM and NORT and preserved hippocampal neuronal morphology. Effects were comparable between sexes and between the two melatonin doses. Conclusion: Melatonin effectively mitigates fluoride-induced neurotoxicity and cognitive dysfunction in Wistar rats by modulating oxidative stress, neuroinflammation, apoptosis, and SIRT1 signaling. These findings highlight melatonin as a promising neuroprotective agent against environmental fluoride toxicity, with potential translational relevance for fluorosis-endemic areas. Keywords: cognitive dysfunction, fluoride neurotoxicity, melatonin, neuroinflammation, neuroprotection, oxidative stress, SIRT1, Wistar rats.
- 28 June 2026
- Published by Veterinary World in Veterinary World
- Vol. 19 (6) , 2650-2666
Open AccessMelatonin attenuates fluoride-induced neurotoxicity and cognitive dysfunction through modulation of oxidative stress, neuroinflammation, and SIRT1 signaling in Wistar rats
Background and Aim: Chronic fluoride exposure causes neurotoxicity, oxidative stress, neuroinflammation, and cognitive impairment, posing a significant public health concern. This study investigated the neuroprotective potential of melatonin against fluoride-induced neurotoxicity and cognitive dysfunction in male and female Wistar rats, with emphasis on oxidative stress, neuroinflammation, apoptosis, and sirtuin 1 (SIRT1) signaling. Materials and Methods: Four-week-old Wistar albino rats (n=8 per group per sex) were exposed to sodium fluoride (NaF, 50 ppm in drinking water) alone or co-treated with melatonin (10 or 20 mg/kg, oral) for 8 weeks. Cognitive function was assessed using the Morris Water Maze (MWM) and Novel Object Recognition Test (NORT). Serum fluoride, brain SIRT1, oxidative stress markers (malondialdehyde [MDA], superoxide dismutase [SOD]), apoptosis markers (caspase-3, B-cell lymphoma 2 [Bcl-2]), inflammatory cytokines (tumor necrosis factor-α [TNF-α], interleukin-6 [IL-6]), acetylcholinesterase (AChE) levels, and hippocampal histopathology were evaluated. Results: NaF exposure significantly elevated serum fluoride, reduced brain SIRT1, increased oxidative stress, apoptosis, neuroinflammation, AChE activity, and caused hippocampal neuronal damage, leading to impaired learning and memory in both sexes (p < 0.05). Melatonin co-treatment (both doses) significantly attenuated these changes by lowering serum fluoride, restoring SIRT1 levels, reducing MDA, caspase-3, TNF-α, IL-6, and AChE, while increasing SOD and Bcl-2. It also improved behavioral performance in the MWM and NORT and preserved hippocampal neuronal morphology. Effects were comparable between sexes and between the two melatonin doses. Conclusion: Melatonin effectively mitigates fluoride-induced neurotoxicity and cognitive dysfunction in Wistar rats by modulating oxidative stress, neuroinflammation, apoptosis, and SIRT1 signaling. These findings highlight melatonin as a promising neuroprotective agent against environmental fluoride toxicity, with potential translational relevance for fluorosis-endemic areas. Keywords: cognitive dysfunction, fluoride neurotoxicity, melatonin, neuroinflammation, neuroprotection, oxidative stress, SIRT1, Wistar rats.
- Open Access
- 1 January 2026
- Published by Wiley in Journal of Toxicology
- Vol. 2026 (1)
Investigating the Protective Role of Folic Acid in Fluoride‐Induced Neurotoxicity: An Integrative Computational and In Vivo Study
Background: Excessive fluoride exposure has been associated with neurotoxicity, including cognitive deficits and an increased risk of dementia. SIRT1, a key regulator of oxidative stress, apoptosis, and inflammation, is downregulated in fluoride‐induced neurotoxicity. This study aimed to identify a potential nutraceutical compound that modulates SIRT1 and explore its effects in a rat model of fluoride‐induced neurotoxicity. Methods: Comprehensive computational approaches, including molecular docking, ADMET predictions, and molecular simulations, were employed. Rats were exposed to 50 ppm sodium fluoride (NaF) alone or cotreated with folic acid (FA; 2.5 or 5 mg/kg) for 8 weeks. NaF was provided in drinking water, and FA was administered via oral gavage. Neurotoxicity was assessed using behavioral paradigms (Morris water maze, novel object recognition test), along with the evaluation of SIRT1 levels, oxidative stress markers, apoptosis, inflammatory cytokines, acetylcholinesterase, and hippocampal histopathology. Results: Computational screening identified FA as a potential SIRT1 modulator. NaF treatment reduced brain SIRT1 levels ( p < 0.05) and was accompanied by increased oxidative stress, apoptosis, and inflammation, leading to learning and memory deficits. FA cotreatment mitigated these alterations, improving behavioral performance, preserving hippocampal structure, and restoring key biochemical markers. FA increased SIRT1, SOD, and Bcl2 levels, while reducing MDA, caspase 3, TNF‐ α , IL‐6, and AChE levels. Conclusion: FA may exert protective effects against fluoride‐induced neurotoxicity, potentially through SIRT1 activation and the modulation of oxidative stress, apoptosis, and inflammation. However, further in‐depth studies are needed to better understand its precise protective mechanisms and evaluate its translational relevance, particularly the extent to which SIRT1 activation contributes to these effects.
- 1 January 2026
- Published by Wiley in Journal of Toxicology
- Vol. 2026 (1)
Open AccessInvestigating the Protective Role of Folic Acid in Fluoride‐Induced Neurotoxicity: An Integrative Computational and In Vivo Study
Background: Excessive fluoride exposure has been associated with neurotoxicity, including cognitive deficits and an increased risk of dementia. SIRT1, a key regulator of oxidative stress, apoptosis, and inflammation, is downregulated in fluoride‐induced neurotoxicity. This study aimed to identify a potential nutraceutical compound that modulates SIRT1 and explore its effects in a rat model of fluoride‐induced neurotoxicity. Methods: Comprehensive computational approaches, including molecular docking, ADMET predictions, and molecular simulations, were employed. Rats were exposed to 50 ppm sodium fluoride (NaF) alone or cotreated with folic acid (FA; 2.5 or 5 mg/kg) for 8 weeks. NaF was provided in drinking water, and FA was administered via oral gavage. Neurotoxicity was assessed using behavioral paradigms (Morris water maze, novel object recognition test), along with the evaluation of SIRT1 levels, oxidative stress markers, apoptosis, inflammatory cytokines, acetylcholinesterase, and hippocampal histopathology. Results: Computational screening identified FA as a potential SIRT1 modulator. NaF treatment reduced brain SIRT1 levels ( p < 0.05) and was accompanied by increased oxidative stress, apoptosis, and inflammation, leading to learning and memory deficits. FA cotreatment mitigated these alterations, improving behavioral performance, preserving hippocampal structure, and restoring key biochemical markers. FA increased SIRT1, SOD, and Bcl2 levels, while reducing MDA, caspase 3, TNF‐ α , IL‐6, and AChE levels. Conclusion: FA may exert protective effects against fluoride‐induced neurotoxicity, potentially through SIRT1 activation and the modulation of oxidative stress, apoptosis, and inflammation. However, further in‐depth studies are needed to better understand its precise protective mechanisms and evaluate its translational relevance, particularly the extent to which SIRT1 activation contributes to these effects.
- Open Access
- 28 February 2024
- Published by Springer Nature in Biological Trace Element Research
- Vol. 202 (12) , 5395-5412
Role of SIRT1 in Potentially Toxic Trace Elements (Lead, Fluoride, Aluminum and Cadmium) Associated Neurodevelopmental Toxicity
The formation of the central nervous system is a meticulously planned and intricate process. Any modification to this process has the potential to disrupt the structure and operation of the brain, which could result in deficiencies in neurological growth. When neurotoxic substances are present during the early stages of development, they can be exceptionally dangerous. Prenatally, the immature brain is extremely vulnerable and is therefore at high risk in pregnant women associated with occupational exposures. Lead, fluoride, aluminum, and cadmium are examples of possibly toxic trace elements that have been identified as an environmental concern in the aetiology of a number of neurological and neurodegenerative illnesses. SIRT1, a member of the sirtuin family has received most attention for its potential neuroprotective properties. SIRT1 is an intriguing therapeutic target since it demonstrates important functions to increase neurogenesis and cellular lifespan by modulating multiple pathways. It promotes axonal extension, neurite growth, and dendritic branching during the development of neurons. Additionally, it contributes to neurogenesis, synaptic plasticity, memory development, and neuroprotection. This review summarizes the possible role of SIRT1 signalling pathway in potentially toxic trace elements -induced neurodevelopmental toxicity, highlighting some molecular pathways such as mitochondrial biogenesis, CREB/BDNF and PGC-1α/NRF1/TFAM.
- 28 February 2024
- Published by Springer Nature in Biological Trace Element Research
- Vol. 202 (12) , 5395-5412
Open AccessRole of SIRT1 in Potentially Toxic Trace Elements (Lead, Fluoride, Aluminum and Cadmium) Associated Neurodevelopmental Toxicity
The formation of the central nervous system is a meticulously planned and intricate process. Any modification to this process has the potential to disrupt the structure and operation of the brain, which could result in deficiencies in neurological growth. When neurotoxic substances are present during the early stages of development, they can be exceptionally dangerous. Prenatally, the immature brain is extremely vulnerable and is therefore at high risk in pregnant women associated with occupational exposures. Lead, fluoride, aluminum, and cadmium are examples of possibly toxic trace elements that have been identified as an environmental concern in the aetiology of a number of neurological and neurodegenerative illnesses. SIRT1, a member of the sirtuin family has received most attention for its potential neuroprotective properties. SIRT1 is an intriguing therapeutic target since it demonstrates important functions to increase neurogenesis and cellular lifespan by modulating multiple pathways. It promotes axonal extension, neurite growth, and dendritic branching during the development of neurons. Additionally, it contributes to neurogenesis, synaptic plasticity, memory development, and neuroprotection. This review summarizes the possible role of SIRT1 signalling pathway in potentially toxic trace elements -induced neurodevelopmental toxicity, highlighting some molecular pathways such as mitochondrial biogenesis, CREB/BDNF and PGC-1α/NRF1/TFAM.
- 1 December 2021
- Published by Elsevier in European Journal of Pharmacology
- Vol. 913, 174624
Trimetazidine an emerging paradigm in renal therapeutics: Preclinical and clinical insights
- 1 December 2021
- Published by Elsevier in European Journal of Pharmacology
- Vol. 913, 174624
Trimetazidine an emerging paradigm in renal therapeutics: Preclinical and clinical insights